This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Analysts' Actions: AMGN, DOW, GDOT, S, XOM

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

AmerisourceBergen (ABC) upgraded at Baird from Neutral to Outperform, Robert Baird said. $46 price target. Comps are easing and earnings growth should accelerate.

Amgen (AMGN) upgraded at Piper from Neutral to Overweight, Piper Jaffray said. $95 price target. Base business appears to have stabilized.

Acme Packet (APKT) downgraded at Pacific Crest to Sector Perform, Pacific Crest said. Company is seeing lower orders from its largest customers.

BGC Partners (BGCP) downgraded to hold at TheStreet Ratings.

Boston Scientific (BSX) downgraded to sell at TheStreet Ratings.

Colgate-Palmolive (CL) downgraded at Deutsche to Hold, Deutsche Bank said. Valuation call, based on a $105 price target.

Coinstar (CSTR) downgraded at Pacific Crest from Outperform to Sector Perform, Pacific Crest said. Company is seeing slower growth at Redbox.

Dow Chemical (DOW) downgraded at Morgan Stanley from Overweight to Equal-weight, Morgan Stanley said. Company faces macro headwinds in the near- and medium-term.

Emcor (EME) downgraded at FBR from Outperform to Market Perform, FBR Capital Markets said. $26 price target. Organic backlog continues to decline.

Expedia (EPXE) upgraded at Morgan Stanley to Equal-weight, Morgan Stanley said. Company has solid sales growth momentum.

Green Dot (GDOT) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $20 price target. Estimates also cut, as the company slashed its guidance.

Green Dot downgraded at JMP from Outperform to Market Perform, JMP Securities said. Estimates also cut, as the company is facing increased competition.

Green Dot downgraded at KBW from Outperform to Market Perform, Keefe, Bruyette & Woods said. Estimates also cut, given the company's new guidance. $20 price target.

HealthSouth Corporation (HLS) downgraded at Jefferies to Hold from Buy, Jefferies said. $23 price target. Rate risk rises. Hold rating.

Snyder's-Lance (LNCE) rated new Hold at Deutsche Bank. Valuation call, based on a $24 price target.

MetroPCS (PCS) upgraded at Deutsche to Buy. $12 price target. Stock still has another 40% upside potential, as expectations remain low.

QLogic (QLGC) downgraded at Pacific Crest to Underperform, Pacific Crest said. Business is in a secular decline.

Raytheon (RTN) downgraded at BofA/Merrill from Buy to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $56 price target.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7870 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs